About Us

Jackson Acquisition Company II (“NYSE: JACS.U”) is a Special Purpose Acquisition Company (SPAC) that seeks to acquire a private healthcare services company that would benefit from a public listing and otherwise gaining access to public capital.

Company Contact

2655 Northwinds Parkway
Alpharetta, GA 30009

(678) 690-1079

Portrait

Richard L. Jackson, Chairman & CEO

  • Founder, Chairman, and CEO of Jackson Healthcare, which includes 25 leading healthcare staffing, executive search, and tech companies
  • Arranged over $4B in financing and manages $4B+ in assets at Jackson Investment Group
  • Owned and managed hospitals, surgery centers, allergy practices, PPOs, managed care, pain centers, medical practices, and healthcare software
  • Developed and launched over 25 companies throughout his career
Download Hi-resolution Image
Portrait

Dave Lawrence, CFO

  • CFO since September 2024, with 20+ years of biotech financial leadership.
  • CFO of Neurotrauma Sciences (March 2021–November 2023); leadership roles at Acorda Therapeutics (1999–2021).
  • Managed Acorda’s IPO, follow-on offerings, and private placements.
  • Holds a B.A. in Accounting from Roger Williams College and an MBA in Finance from Iona University.
Download Hi-resolution Image
Portrait

Brian McCarthy, Independent Director

  • Advised on 125+ healthcare transactions totaling over $100B
  • Vice Chairman of Healthcare Investment Banking at Lehman, J.P. Morgan, and Bank of America
  • Member of Patient Square’s Advisory Council and Intus Care Advisory Board
  • B.A. from Brown (1981) and M.B.A. from Wharton (1986)
Portrait

James Nicholas Ayers, Independent Director

  • Former Chief of Staff to VP Mike Pence (2017-2019) and Executive Chairman of the Republican Governors Association.
  • Partner and Director at C6 Creative Consulting, founded in 2019.
  • Board member at Veeam Software, PSQ Holdings, and Leading the Way Ministry.
  • Holds a B.S. in Political Science from Kennesaw State University.
Portrait

Paul Gabos, Independent Director

  • Co-Founder and Chairman of Kaliber Labs, Inc. since 2018.
  • CFO of Lincare Holdings for nearly 20 years, leading its $4.7B acquisition by The Linde Group.
  • Board member at MEDNAX, Benefytt Technologies, and Life Line Screening Holdings.
  • Started as an M&A specialist at Dean Witter Reynolds and Coopers & Lybrand; holds a B.S. in Economics from Wharton.
Portrait

Stephan Rodgers, Independent Director

  • 25+ years in healthcare across homecare, insurance, consulting, and employee benefits.
  • CEO of AccentCare (2012–October 2023); senior roles at UnitedHealth Group.
  • Operating Partner at TowerBrook Capital Partners since January 2024, focusing on healthcare investments.
  • Began healthcare career as a U.S. Army medic; holds a B.A. in Biochemistry from UC.

Press Releases

committee composition